TransEnterix (TRXC) has risen sharply, recording gains of 4.48% in the past 4 weeks. However, the stock has corrected -1.41% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 4.08% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
TransEnterix, Inc. has dropped 22.22% during the last 3-month period . Year-to-Date the stock performance stands at -43.55%. The stock has recorded a 20-day Moving Average of 0.94% and the 50-Day Moving Average is 4.43%.
TransEnterix (NYSEMKT:TRXC): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $1.38 and $1.33 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $1.40. The buying momentum continued till the end and the stock did not give up its gains. It closed at $1.40, notching a gain of 2.19% for the day. The total traded volume was 514,390 . The stock had closed at $1.37 on the previous day.
Also, Equity Analysts at the BTIG Research downgrades the rating on TransEnterix (NYSEMKT:TRXC). The brokerage firm has issued a Neutral rating on the shares. The shares were previously rated Buy. The rating by the firm was issued on April 18, 2016.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.